Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Neurology and Therapy|May 12, 2023
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database AnalysisColin Anderson-Smits, Mary E Ritchey, Zhongwen Huang, et al.
Drugs - Real World Outcomes|May 23, 2023
Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive BladderJingjun Wang, Mary E Ritchey, Kamika Reynolds, et al.
Plos One|January 27, 2021
Increased risk of falls and fractures in patients with psychosis and Parkinson diseaseJoan Forns, J Bradley Layton, Jennifer Bartsch, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2019
Engaging stakeholders in pharmacoepidemiology research: Current state and recommendationsWendy Camelo Castillo, Nicholas Heath, John Kim, et al.
Drugs - Real World Outcomes|December 1, 2022
CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims AnalysisMary E Ritchey, Jingjun Wang, Jessica C Young, et al.
BMC Cancer|August 29, 2021
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature reviewMichelle D Hackshaw, Heather E Danysh, Mackenzie Henderson, et al.
Patient Education and Counseling|March 14, 2024
Communicating medical device recalls: A rapid review of the literatureBethany L Tennant, Casey Langer Tesfaye, Melanie C Chansky, et al.
Breast Cancer Research and Treatment|June 28, 2020
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancerMichelle D Hackshaw, Heather E Danysh, Jasmeet Singh, et al.
Drugs - Real World Outcomes|October 31, 2021
Falls and Fractures in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort StudyJ Bradley Layton, Joan Forns, Mary Ellen Turner, et al.
JACC. Heart Failure|March 14, 2014
Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of ∼ 145,000 patientsZak Loring, Daniel A Caños, Kimberly Selzman, et al.
Pageof 4